The Campbell’s Company (CPB) Q3 2026 (Q&A) earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 (Q&A) earnings summary
8 Jun, 2026Executive summary
Net sales declined 4% year-over-year to $2.37 billion, mainly due to lower volume/mix and divestitures, partially offset by favorable net price realization.
Gross profit margin declined to 27.5% from 29.4%, impacted by tariffs, cost inflation, and supply chain costs, partially offset by productivity improvements and pricing.
EPS increased to $0.41 from $0.22, while adjusted EPS dropped 32% to $0.50, mainly from lower adjusted EBIT.
Recent developments include the acquisition of a 49% stake in La Regina and the completion of divestitures of Pop Secret and noosa yoghurt businesses.
Management reaffirmed full-year fiscal 2026 guidance, focusing on cost savings and portfolio simplification to offset inflationary pressures.
Financial highlights
Q3 FY26 net sales declined 4% year-over-year to $2.37 billion; organic net sales also down 4%.
Adjusted EBIT dropped 24% to $274 million, with margin contracting to 11.6% from 14.6%.
Adjusted EPS fell 32% to $0.50, reflecting lower EBIT and tariff impacts.
Gross profit for the quarter was $650 million, with a margin of 27.5%; for the nine months, gross profit margin was 28.4%, down from 30.4% year-over-year.
Net earnings attributable to shareholders were $124 million for the quarter, up from $66 million year-over-year.
Outlook and guidance
Fiscal 2026 organic net sales expected to decline 2% to 1% year-over-year.
Adjusted EBIT guidance: down 20% to 17% from prior year; adjusted EPS guidance: down 26% to 23%, range of $2.15 to $2.25.
Elevated inflationary pressures, tariffs, and supply chain costs are expected to persist through 2026.
Annual ongoing savings from cost initiatives are targeted at $375 million by the end of 2028, with $200 million achieved to date.
Guidance excludes impact of 53rd week in fiscal 2025 and recent divestitures.
Latest events from The Campbell’s Company
- Sales and earnings fell sharply, leading to a downward revision of full-year guidance.CPB
Q2 2026 Prepared remarks9 Jun 2026 - Net sales and adjusted EPS fell, but guidance and cost-saving progress were maintained.CPB
Q3 2026 Prepared remarks8 Jun 2026 - Net sales and earnings fell, prompting lower guidance and accelerated cost-saving actions.CPB
Q2 2026 (Q&A)11 Mar 2026 - Snacking and premium brands drive growth, with margin expansion and meals recovery underway.CPB
4th Annual Evercore ISI Consumer and Retail Conference3 Feb 2026 - Q3 net sales up 6% and adjusted EPS up 10%, led by Sovos Brands and margin gains.CPB
Q3 202431 Jan 2026 - Q4 adjusted EPS up 26% with Sovos integration; FY25 targets 9–11% sales growth.CPB
Q4 202423 Jan 2026 - Targets 2–3% sales and 7–9% EPS growth by 2027, led by brand focus, innovation, and supply chain excellence.CPB
Investor Day 202421 Jan 2026 - Director elections, auditor ratification, and strategic growth highlighted; diversity audit rejected.CPB
AGM 202413 Jan 2026 - Net sales up 10% to $2.8B, adjusted EPS down 2%, dividend raised, CEO transition announced.CPB
Q1 202512 Jan 2026